Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4129820
Max Phase: Preclinical
Molecular Formula: C18H15Cl3N4O3
Molecular Weight: 441.70
Molecule Type: Small molecule
Associated Items:
ID: ALA4129820
Max Phase: Preclinical
Molecular Formula: C18H15Cl3N4O3
Molecular Weight: 441.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCl)Nc1ccc(-n2nc(OCCO)nc2-c2ccc(Cl)c(Cl)c2)cc1
Standard InChI: InChI=1S/C18H15Cl3N4O3/c19-10-16(27)22-12-2-4-13(5-3-12)25-17(23-18(24-25)28-8-7-26)11-1-6-14(20)15(21)9-11/h1-6,9,26H,7-8,10H2,(H,22,27)
Standard InChI Key: UHRHTDONQDPBHO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.70 | Molecular Weight (Monoisotopic): 440.0210 | AlogP: 3.79 | #Rotatable Bonds: 7 |
Polar Surface Area: 89.27 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.21 | CX LogD: 4.21 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.54 | Np Likeness Score: -1.60 |
1. Wu G, Wang H, Zhou W, Zeng B, Mo W, Zhu K, Liu R, Zhou J, Chen C, Chen H.. (2018) Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors., 26 (12): [PMID:29751989] [10.1016/j.bmc.2018.04.059] |
Source(1):